NextPoint Therapeutics Stock

NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients.

Sign up today and learn more about NextPoint Therapeutics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About NextPoint Therapeutics Stock

NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. The company offers immunotherapies for a validated checkpoint axis that is independent of PD-1/L1 and modulates both adaptive and innate immune systems to find and destroy cancer cells.

Funding History

January 2023$80.0M

Management

Scientific Co-Founder

Xingxing Zang

Scientific Co-Founder

Gordon Freeman

Board of Directors

Rakhshita Dhar

Chief Medical Officer

Leena Gandhi

Board of Directors

Paulina Hill

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo